AWAU
WST icon

Alliance Wealth Advisors (Utah)’s West Pharmaceutical WST Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,206
Closed -$270K – 292
2025
Q1 		$270K Buy
1,206
+1
+0.1% +$276 0.07% 224
2024
Q4 		$395K Sell
1,205
-2
-0.2% -$629 0.1% 182
2024
Q3 		$362K Sell
1,207
-5
-0.4% -$1.53K 0.1% 184
2024
Q2 		$399K Buy
1,212
+5
+0.4% +$1.77K 0.12% 165
2024
Q1 		$478K Sell
1,207
-29
-2% -$10.7K 0.14% 143
2023
Q4 		$435K Buy
1,236
+13
+1% +$4.6K 0.15% 150
2023
Q3 		$459K Buy
1,223
+12
+1% +$4.64K 0.17% 130
2023
Q2 		$463K Sell
1,211
-20
-2% -$7.14K 0.17% 128
2023
Q1 		$427K Buy
1,231
+52
+4% +$15.2K 0.17% 127
2022
Q4 		$277K Buy
+1,179
New +$279K 0.12% 169

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s WST Position: Q2 2025 in Review

Alliance Wealth Advisors (Utah) sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 1,206 shares — an estimated $270K sold.

Alliance Wealth Advisors (Utah) first reported a position in WST in Q4 2022 and held it in 10 quarters. The position peaked at $478K in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Alliance Wealth Advisors (Utah) reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Alliance Wealth Advisors (Utah) sold 1,206 West Pharmaceutical shares in Q2 2025, an estimated $270K.
  • Alliance Wealth Advisors (Utah) first reported a position in West Pharmaceutical in Q4 2022 and held it in 10 quarters.
  • Alliance Wealth Advisors (Utah)'s West Pharmaceutical position peaked at $478K in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2025, filed 14 Aug 2025.